etoposide has been researched along with resazurin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bleibel, WK; Blume, JE; Chen, TX; Clark, TA; Cox, NJ; Dolan, ME; Duan, S; Huang, RS; Kistner, EO; Schweitzer, AC; Zhang, W | 1 |
Al-Rubai, AJ; Grabowska, AM; Ivanov, DP; Pratten, MK | 1 |
2 other study(ies) available for etoposide and resazurin
Article | Year |
---|---|
A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.
Topics: Antineoplastic Agents, Phytogenic; Black People; Cell Line; Cell Proliferation; Etoposide; Gene Expression Regulation; Genetic Variation; Humans; Inhibitory Concentration 50; Linear Models; Oligonucleotide Array Sequence Analysis; Oncogenes; Oxazines; Pharmacogenetics; Polymorphism, Single Nucleotide; White People; Xanthenes | 2007 |
Separating chemotherapy-related developmental neurotoxicity from cytotoxicity in monolayer and neurosphere cultures of human fetal brain cells.
Topics: Antineoplastic Agents; Astrocytes; Brain; Cell Count; Cell Culture Techniques; Cell Survival; Cells, Cultured; Etoposide; Fetus; Glial Fibrillary Acidic Protein; Humans; Methylmercury Compounds; Neurons; Neurotoxicity Syndromes; Oxazines; Oxidation-Reduction; Spheroids, Cellular; Teniposide; Tubulin; Xanthenes | 2016 |